Successful treatment of infants with localized neuroblastoma based on their MYCN status-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of infants with localized neuroblastoma based on their MYCN status

Published:2012-03-02 Issue:3 Volume:18 Page:389-395
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Iehara Tomoko, ,Hamazaki Minoru,Tajiri Tatsuro,Kawano Yoshifumi,Kaneko Michio,Ikeda Hitoshi,Hosoi Hajime,Sugimoto Tohru,Sawada Tadashi

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-012-0391-y.pdf

Reference24 articles.

1. Sawada T, Nishi M, Takeda T et al (1998) Mass screening for neuroblastoma in Japan. Med Pediatr Oncol 31:429–434

2. Sawada T, Hirayama M, Nakata T et al (1984) Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening group. Lancet 2:271–273

3. Hachitanda Y, Ishimoto K, Hata J et al (1994) One hundred neuroblastomas detected through a mass screening system in Japan. Cancer 74:3223–3226

4. Castleberry RP, Shuster JJ, Altshluer G et al (1992) Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group Study. J Clin Oncol 10:1299–1304

5. Garaventa A, Boni L, Lo Piccolo MS et al (1993) Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma. J Clin Oncol 1:1770–1779

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Knowledge and Perspectives of Immunotherapies for Neuroblastoma;Cancers;2024-08-17

2. The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches;Cancers;2024-05-13

3. Pirarubicin Combination Low-Dose Chemotherapy for Early Infantile Stage MS Neuroblastoma: Case Report;Children;2023-05-12

4. Advancing therapy for neuroblastoma;Nature Reviews Clinical Oncology;2022-05-25

5. Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children’s Cancer Group Neuroblastoma Committee (JCCG-JNBSG);Biomolecules;2021-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3